Key Takeaway: Spending slightly more for peptides from verified sources represents smart economics
Final Thoughts BPC-157 peptide therapy continues gaining attention in wellness and recovery-focused care, but patients should understand that peptide therapy is not risk-free
Lyophilized compounds, solution preparations, encapsulated products, and aerosol research products should be reviewed using the applicable product label, COA, and internal laboratory handling standards
Bestellungen gehen in der Reihenfolge des Eingangs raus, die Lieferzeit betrgt aktuell 1 bis 3 Wochen
DSIP is not currently listed on the WADA Prohibited List as of 2026
Recalls & Warnings January 21, 2018 Joint Supplement Recalled for Salmonella Risk On January 21, 2018, Arthri-D, LLC announced a recall of its joint pain supplement, Arthri-D (120 count), due to possible Salmonella contamination